The importance of acetyl coenzyme A synthetase for 11C-acetate uptake and cell survival in hepatocellular carcinoma

Journal of Nuclear Medicine

Volumn 50, Issue 8, 2009, Pages 1222-1228

  Yun, Mijin ^a   Bang, Seong Hye ^a   Jae, Woo Kim ^a   Jun, Young Park ^a   Kyoung, Sup Kim ^a   Jong, Doo Lee ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

11C acetate; 18F FDG; Acetyl CoA synthetase; Fatty acid synthesis; Hepatocellular carcinoma

Indexed keywords

ACETIC ACID C 11; ACETYL COENZYME A CARBOXYLASE; ACETYL COENZYME A SYNTHETASE; ACETYL COENZYME A SYNTHETASE 1; ACETYL COENZYME A SYNTHETASE 2; ADENOSINE TRIPHOSPHATE CITRATE LYASE; FATTY ACID SYNTHASE; FLUORODEOXYGLUCOSE F 18; GLUCOSE; HEXOKINASE; HEXOKINASE 2; SMALL INTERFERING RNA; TRACER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GROWTH; CELL LINE; CELL SURVIVAL; CELL VIABILITY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG UPTAKE; FEMALE; GENE EXPRESSION; GLYCOLYSIS; HUMAN; HUMAN CELL; LIPOGENESIS; LIVER CELL CARCINOMA; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ACETATE-COA LIGASE; ACETATES; ADULT; AGED; CARBON; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL SURVIVAL; FATTY ACID SYNTHETASE COMPLEX; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER NEOPLASMS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; RADIOPHARMACEUTICALS;

EID: 68249161944     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.109.062703     Document Type: Article

References (33)

1. Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. J Gen Physiol. 1926;8:519-530.
2. 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses. J Nucl Med. 2003;44:213-221.
3. 18F]fluorodeoxyglucose in untreated prostate cancer. Jpn J Clin Oncol. 1999;29: 623-629.
4. 11C-acetate. J Nucl Med. 2003;44:556-558.
5. Kang DE, White RL Jr, Zuger JH, Sasser HC, Teigland CM. Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma. J Urol. 2004;171:1806-1809.
6. Visser FC. Imaging of cardiac metabolism using radiolabelled glucose, fatty acids and acetate. Coron Artery Dis. 2001;12(suppl 1):S12-S18.
7. Shreve P, Chiao PC, Humes HD, Schwaiger M, Gross MD. Carbon-11-acetate PET imaging in renal disease. J Nucl Med. 1995;36:1595-1601.
8. Oyama N, Akino H, Kanamaru H, et al. 11C-acetate PET imaging of prostate cancer. J Nucl Med. 2002;43:181-186.
9. Yoshimoto M, Waki A, Yonekura Y, et al. Characterization of acetate metabolism in tumor cells in relation to cell proliferation: acetate metabolism in tumor cells. Nucl Med Biol. 2001;28:117-122.
10. Vavere AL, Kridel SJ, Wheeler FB, Lewis JS. 1-11C-acetate as a PET radiopharmaceutical for imaging fatty acid synthase expression in prostate cancer. J Nucl Med. 2008;49:327-334.
11. Weiss L, Hoffmann GE, Schreiber R, et al. Fatty-acid biosynthesis in man, a pathway of minor importance: purification, optimal assay conditions, and organ distribution of fatty-acid synthase. Biol Chem Hoppe Seyler. 1986;367: 905-912.
12. Kuhajda FP, Jenner K, Wood FD, et al. Fatty acid synthesis: a potential selective target for antineoplastic therapy. Proc Natl Acad Sci USA. 1994;91:6379-6383.
13. Medes G, Thomas A, Weinhouse S. Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro. Cancer Res. 1953; 13:27-29.
14. Kuhajda FP. Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition. 2000;16:202-208.
15. Alo PL, Visca P, Marci A, Mangoni A, Botti C, Di Tondo U. Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients. Cancer. 1996;77:474-482.
16. Shurbaji MS, Kalbfleisch JH, Thurmond TS. Immunohistochemical detection of a fatty acid synthase (OA-519) as a predictor of progression of prostate cancer. Hum Pathol. 1996;27:917-921.
17. Rashid A, Pizer ES, Moga M, et al. Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. Am J Pathol. 1997;150: 201-208.
18. Baron A, Migita T, Tang D, Loda M. Fatty acid synthase: a metabolic oncogene in prostate cancer? J Cell Biochem. 2004;91:47-53.
19. Olson RE. Oxidation of C14-labeled carbohydrate intermediates in tumor and normal tissue. Cancer Res. 1951;11:571-584.
20. Zamecnik PC, Loftfield RB, Stephenson ML, Steele JM. Studies on the carbohydrate and protein metabolism of the rat hepatoma. Cancer Res. 1951;11: 592-602.
21. Hatzivassiliou G, Zhao F, Bauer DE, et al. ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell. 2005;8:311-321.
22. Coleman PS. Membrane cholesterol and tumor bioenergetics. Ann N Y Acad Sci. 1986;488:451-467.
23. Bailey JM, Howard BV, Dunbar LM, Tillman SF. Control of lipid metabolism in cultured cells. Lipids. 1972;7:125-134.
24. Howard BV. Acetate as a carbon source for lipid synthesis in cultured cells. Biochim Biophys Acta. 1977;488:145-151.
25. Wolin M, Miller T. Carbohydrate fermentation. In: Hentges DA, ed. Human Intestinal Flora in Health and Disease. New York, NY: Academic; 1983:147-165.
26. Seufert CD, Graf M, Janson G, Kuhn A, Soling HD. Formation of free acetate by isolated perfused livers from normal, starved and diabetic rats. Biochem Biophys Res Commun. 1974;57:901-909.
27. Trojan J, Schroeder O, Raedle J, et al. Fluorine-18FDG positron emission tomography for imaging of hepatocellular carcinoma. Am J Gastroenterol. 1999;94:3314-3319.
28. Kong YH, Han CJ, Lee SD, et al. Korean J Hepatol. 2004;10:279-287.
29. Hatano E, Ikai I, Higashi T, et al. Preoperative positron emission tomography with fluorine-18-fluorodeoxyglucose is predictive of prognosis in patients with hepatocellular carcinoma after resection. World J Surg. 2006;30:1736-1741.
30. 18F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients. Liver Transpl. 2006;12:1655-1660.
31. Fujino T, Kondo J, Ishikawa M, Morikawa K, Yamamoto TT. Acetyl-CoA synthetase 2, a mitochondrial matrix enzyme involved in the oxidation of acetate. J Biol Chem. 2001;276:11420-11426.
32. Goldberg RP, Brunengraber H. Contributions of cytosolic and mitochondrial acetyl-CoA syntheses to the activation of lipogenic acetate in rat liver. Adv Exp Med Biol. 1980;132:413-418.
33. Luong A, Hannah VC, Brown MS, Goldstein JL. Molecular characterization of human acetyl-CoA synthetase, an enzyme regulated by sterol regulatory element-binding proteins. J Biol Chem. 2000;275:26458-26466.